Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery
Diabetes Technology & Therapeutics · 2023-03 · 25 (3) · 206-211
DOI: 10.1089/dia.2022.0400 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 28.02.2023. Verfasst von Gabija Krutkyte und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The central role of pancreas in glucose regulation imposes high demands on perioperative glucose management in patients undergoing pancreatic surgery. In a post hoc subgroup analysis of a randomized controlled trial, we evaluated the perioperative use of subcutaneous (SC) fully closed-loop (FCL; CamAPS HX) versus usual care (UC) insulin therapy in patients undergoing partial or total pancreatic resection. Glucose control was compared using continuous glucose monitoring (CGM) metrics (% time with CGM values between 5.6 and 10.0 mmol/L and more). Over the time of hospitalization, FCL resulted in better glucose control than UC with more time spent in the target range 5.6–10.0 mmol/L (mean [standard deviation] % time in target 77.7% ± 4.6% and 41.1% ± 19.5% in FCL vs. UC subjects, respectively; mean difference 36.6% [95% confidence interval 18.5–54.8]), without increasing the risk of hypoglycemia. Findings suggest that an adaptive SC FCL approach effectively accommodated the highly variable insulin needs in patients undergoing pancreatic surgery. Clinical trials registration: ClinicalTrials.gov, NCT04361799.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Anaesthesiology and Pain Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Nephrology and Hypertension Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
- Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
ORCID-Profile: Lia Bally
Zitieren
APA
Krutkyte, G., Roos, J., Schuerch, D., Czerlau, C., Wilinska, M. E., Wuethrich, P. Y., Herzig, D., Hovorka, R., Vogt, A. P., Gloor, B., & Bally, L. (2023). Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery. Diabetes Technology & Therapeutics, 25(3), 206-211. https://doi.org/10.1089/dia.2022.0400
Vancouver
Krutkyte G, Roos J, Schuerch D, Czerlau C, Wilinska ME, Wuethrich PY, et al. Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery. Diabetes Technology & Therapeutics. 2023;25(3):206-211. doi:10.1089/dia.2022.0400
BibTeX
@article{Krutkyte2023,
author = {Krutkyte, Gabija and Roos, Jonathan and Schuerch, Daniel and Czerlau, Cecilia and Wilinska, Malgorzata E and Wuethrich, Patrick Y and Herzig, David and Hovorka, Roman and Vogt, Andreas P and Gloor, Beat and Bally, Lia},
title = {Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
volume = {25},
number = {3},
pages = {206--211},
doi = {10.1089/dia.2022.0400}
}
EUVIMED